ALL (S) FCCN: News Release ths morning from Yahoo PR News
Tuesday February 9, 5:00 am Eastern Time
Company Press Release
Beloyan Investment Securities, Inc. Announces Investment Opinion on Frontline Communications Corp. and Pediatric Services of America
Beloyan Investment Securities, Inc. Initiates a Strong Buy on Frontline Communications Corp. (FCCN) With a 6-Month Target Price of $20.00 to $25.00 Per Share
DAVIE, Fla.--(BUSINESS WIRE)--Feb. 9, 1999-- Reiterates Buy of Pediatric Services of America (PSAI) With a
6 Month Target Price of $8.25
Beloyan Investment Securities, Inc. President Mark Beloyan issued a Strong Buy on Frontline Communications Corp. (Nasdaq:FCCN - news). The target price of $20 to $25 per share is warranted for the following reasons:
1. Strong Cash position ($2 million) and stock price for future
acquisitions.
2. The ISP marketplace is consolidating and strong growth is
expected.
3. Strong region in which FCCN is located, Middle Eastern Seaboard,
(New York, New Jersey and Pennsylvania)
4. Very little debt - $150,000
5. Is developing an E-commerce site, due out in April 1999, with
concentration in "Women owned Businesses".
6. 15,000 subscribers and growing.
7. DSL (Digital Subscriber Line) technology which utilizes existing
copper wiring to provide high speed internet access, while being
much less expensive than traditional high-speed technology
8. CLEC status, (Competitive Local Exchange Carrier) by the New York
State Public Services Commission. Applications pending in New
Jersey and Pennsylvania.
Chief Investment Strategist Tom Cannon reiterates Strong Buy of Pediatric Services of America (Nasdaq:PSAI - news) citing that a turnaround play with a 6 month target price of $8.25 is warranted for the following reasons:
With respect to the above you should be advised that:
1. Beloyan Investment Securities, Inc. (BIS) may trade for its own
account any securities/options of the issuer(s).
2. BIS, its affiliates, directors and officers may have a long or
short position in any securities mentioned herein.
3. The material herein has been obtained from sources believed
reliable and accurate, however, its accuracy and completeness
cannot be guaranteed. Any recommendation contained therein may
not be suitable for all investors.
For further information please call 800/365-1553.
NOTE: These releases must adhere to all criteria previously set forth
regarding ''acceptable'' copy. If a release is inflammatory, lacks
attribution, is poorly written or has any other ''red flags'' see
your manager immediately.
|
